Prashant Kishor’s Jan Suraaj Scripts Historic First Electoral Victory, Defeats BJP in Bihar’s Bankipur By-Election by 18,953 Votes 
Spanish Government Deploys Troops and Police to Ceuta Border. 
Iran denies US talks claim 
Dollar Falls Against Japanese Yen as Currency Markets React to Central Bank Actions and Global Economic Uncertainty 
Abhijeet Dipke denies plans to enter mainstream politics UK Government Considers Scrapping £330m NHS Contract with Palantir Amid Criticism from Tech Firm’s UK Boss
** The UK government is considering terminating a £330m contract with Palantir after the company’s UK boss urged ministers to resist calls to trigger a break clause. The contract, aimed at improving data sharing between NHS trusts, has raised concerns over data protection and transparency.
government considers scrapping 330m:
The UK government is reportedly seeking to terminate a £330m contract with US-based analytics company Palantir, following criticism from the tech firm’s UK boss about the government’s decision-making process. Louis Mosley, the head of Palantir in the UK, has urged ministers to resist calls from “ideologically motivated campaigners” to trigger a break clause in the deal.
The contract in question is for the delivery of the Federated Data Platform (FDP), a project aimed at improving data sharing between NHS trusts. While details about the contract’s specifics are limited, experts believe that Palantir’s involvement in the project has raised concerns among some about the company’s commitment to transparency and data protection.
Mosley’s comments come as a response to pressure from various groups, including those opposed to Palantir’s involvement in the public sector due to its business ties with government agencies in the United States. Critics argue that the company’s presence in the NHS represents a significant threat to patient data and confidentiality.
The break clause, which the government appears to be considering, would allow them to terminate the deal early and potentially avoid controversy surrounding Palantir’s role in the project. However, experts warn that terminating the contract could have significant financial implications for the NHS, which has already invested heavily in the project.
As the debate surrounding Palantir’s NHS contract continues, it remains unclear whether the government will ultimately decide to trigger the break clause. However, with increasing scrutiny on the company’s activities in the public sector, one thing is certain: the fate of the £330m contract hangs in the balance.
